BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 29748775)

  • 1. Congenital hypodysfibrinogenemia associated with a novel deletion of three residues (γAla289_Asp291del) in fibrinogen.
    Zhu L; Zhao M; Wang M; Lou Z; Chen X; Pan L; Yu D; Xia W; Wang H; Zhou B; Gao S
    J Thromb Thrombolysis; 2018 Aug; 46(2):211-218. PubMed ID: 29748775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysfibrinogenemia-associated novel heterozygous mutation, Shanghai (FGA c.169_180+2 del), leads to N-terminal truncation of fibrinogen Aα chain and impairs fibrin polymerization.
    Zhou J; Ding Q; Wu W; Ouyang Q; Xie Y; Wu X; Lu Y; Dai J; Liang Q; Wang H; Wang X; Hu Y
    J Clin Pathol; 2017 Feb; 70(2):145-153. PubMed ID: 27555433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a novel splicing mutation in the fibrinogen gamma chain gene leading to dysfibrinogenaemia in a Chinese pedigree.
    Huang D; Chen H; Hu X; Wang X; Wang H
    Pathology; 2015 Feb; 47(2):145-50. PubMed ID: 25551304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three cases of congenital dysfibrinogenemia in unrelated Chinese families: heterozygous missense mutation in fibrinogen alpha chain Argl6His.
    Luo M; Deng D; Xiang L; Cheng P; Liao L; Deng X; Yan J; Lin F
    Medicine (Baltimore); 2016 Sep; 95(39):e4864. PubMed ID: 27684817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrin clot properties to assess the bleeding phenotype in unrelated patients with hypodysfibrinogenemia due to novel fibrinogen mutations.
    Marchi R; Vilar R; Durual S; Goodyer M; Gay V; Neerman-Arbez M; Casini A
    Thromb Res; 2021 Jan; 197():56-64. PubMed ID: 33186848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic analyses of novel compound heterozygous hypodysfibrinogenemia, Tsukuba I: FGG c.1129+62_65 del AATA and FGG c.1299+4 del A.
    Mukai S; Nagata K; Ikeda M; Arai S; Sugano M; Honda T; Okumura N
    Thromb Res; 2016 Dec; 148():111-117. PubMed ID: 27837696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Congenital fibrinogen disorder with a compound heterozygote possessing two novel FGB mutations, one qualitative and the other quantitative.
    Yoda M; Kaido T; Taira C; Higuchi Y; Arai S; Okumura N
    Thromb Res; 2020 Dec; 196():152-158. PubMed ID: 32871307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined Congenital Hypodysfibrinogemia and Factor XI Deficiency in a Chinese Family.
    Peng Y; Nie L; Qin C; Wan L; Zhou P
    Acta Haematol; 2020; 143(5):472-477. PubMed ID: 31982874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypodysfibrinogenemia: A novel abnormal fibrinogen associated with bleeding and thrombotic complications.
    Amri Y; Kallel C; Becheur M; Dabboubi R; Elloumi M; Belaaj H; Kammoun S; Messaoud T; de Moerloose P; Toumi Nel H
    Clin Chim Acta; 2016 Sep; 460():55-62. PubMed ID: 27343352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel fibrinogen γ chain frameshift deletion (c.637delT) in a patient with hypodysfibrinogenemia associated with thrombosis.
    Ivaškevičius V; Thomas A; Biswas A; Ensikat H; Schmitt U; Horneff S; Pavlova A; Poetzsch B; Oldenburg J
    Hamostaseologie; 2015; 35 Suppl 1():S27-31. PubMed ID: 26540127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Congenital afibrinogenemia caused by a novel insertion mutation in the FGB gene].
    Zhang J; Zhao XJ; Wang ZY; Yu ZQ; Cao LJ; Ma ZN; Zhang J; Zhang W; Bai X; Ruan CG
    Zhonghua Xue Ye Xue Za Zhi; 2013 Sep; 34(9):751-6. PubMed ID: 24103871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrinogen Philadelphia, a hypodysfibrinogenemia characterized by abnormal polymerization and fibrinogen hypercatabolism due to gamma S378P mutation.
    Keller MA; Martinez J; Baradet TC; Nagaswami C; Chernysh IN; Borowski MK; Surrey S; Weisel JW
    Blood; 2005 Apr; 105(8):3162-8. PubMed ID: 15632207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in the function and secretion of congenital aberrant fibrinogenemia between heterozygous γD320G (Okayama II) and γΔN319-ΔD320 (Otsu I).
    Mukai S; Ikeda M; Takezawa Y; Sugano M; Honda T; Okumura N
    Thromb Res; 2015 Dec; 136(6):1318-24. PubMed ID: 26573395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic and clinical characterization of congenital fibrinogen disorders in Polish patients: Identification of three novel fibrinogen gamma chain mutations.
    Wypasek E; Klukowska A; Zdziarska J; Zawilska K; Treliński J; Iwaniec T; Mital A; Pietrys D; Sydor W; Neerman-Arbez M; Undas A
    Thromb Res; 2019 Oct; 182():133-140. PubMed ID: 31479941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel variant fibrinogen γp.C352R produced hypodysfibrinogenemia leading to a bleeding episode and failure of infertility treatment.
    Yoda M; Kaido T; Kamijo T; Taira C; Higuchi Y; Arai S; Okumura N
    Int J Hematol; 2021 Sep; 114(3):325-333. PubMed ID: 34117991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two symptomatic cases of dysfibrinogenemia in China: one with gamma-chain Arg275Cys mutation and another without detectable mutation in fibrinogen genes.
    Bin Q; Liang F; Ou DY; Cui HR; Luo JM
    Blood Coagul Fibrinolysis; 2015 Jul; 26(5):564-71. PubMed ID: 25828970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetics, diagnosis and clinical features of congenital hypodysfibrinogenemia: a systematic literature review and report of a novel mutation.
    Casini A; Brungs T; Lavenu-Bombled C; Vilar R; Neerman-Arbez M; de Moerloose P
    J Thromb Haemost; 2017 May; 15(5):876-888. PubMed ID: 28211264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro fibrin clot formation and fibrinolysis using heterozygous plasma fibrinogen from gammaAsn319, Asp320 deletion dysfibrinogen, Otsu I.
    Terasawa F; Kani S; Hongo M; Okumura N
    Thromb Res; 2006; 118(5):651-61. PubMed ID: 16412498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of plasmin generation and clot lysis of plasma fibrinogen purified from a heterozygous dysfibrinogenemia, BbetaGly15Cys (Hamamatsu II).
    Kamijyo Y; Hirota-Kawadobora M; Yamauchi K; Terasawa F; Honda T; Ikeya M; Okumura N
    Blood Coagul Fibrinolysis; 2009 Dec; 20(8):726-32. PubMed ID: 19809304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Congenital hypofibrinogenemia associated with a novel mutation in FGG gene].
    Wang Y; Ding H; Hao X; Zhu L; Yang L; Jin Y; Wang M
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2015 Jun; 32(3):331-4. PubMed ID: 26037343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.